3
Announcements
Trials
Browse
Landscape
Status
Completed
2
Active not recruiting
1
Sponsor Class
OTHER
2
Study Type
Observational
2
Sponsor
Cancer Type
Tumor-Agnostic
1
Gastrointestinal
1
Conditions
Breast Neoplasms
4
Prostatic Neoplasms
3
Colorectal Neoplasms
3
Neoplasms
2
Neoplasm Metastasis
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Colonic Neoplasms
2
Untreated Human Epidermal Growth Factor Receptor-2(HER2)Positive Early Breast Cancer
1
Testicular Germ Cell Tumor
1
Stroke
1
Stomach Neoplasms
1
Renal Insufficiency
1
Prostate Cancer Metastatic
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Polycystic Ovary Syndrome
1
Obesity
1
Non-alcoholic Fatty Liver Disease
1
Neoplastic Cells, Circulating
1
Motor Activity
1
Metabolic Syndrome
1
Memory Disorders
1
Melanoma
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Liver Cirrhosis
1
Leukemia, Myeloid, Acute
1
Leukemia
1
Hodgkin Disease
1
Heart Diseases
1
HPV Positive Oropharyngeal Squamous Cell Carcinoma
1
Interventions
Gemcitabine
74
Capecitabine
60
Paclitaxel
59
Fluorouracil
58
Oxaliplatin
57
Bevacizumab
51
Docetaxel
50
Leucovorin
48
Nivolumab
40
Cisplatin
40
Irinotecan
39
Carboplatin
37
Cetuximab
34
pembrolizumab
32
Radiosurgery
32
Trastuzumab
30
Radiotherapy
27
Everolimus
24
Sorafenib
23
Pemetrexed
20
Doxorubicin
20
Albumin-Bound Paclitaxel
20
Ipilimumab
19
Cyclophosphamide
19
Panitumumab
18
Zoledronic Acid
17
Lapatinib
17
Erlotinib Hydrochloride
17
Prednisone
16
pazopanib
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Completed
×
Neoplasm Metastasis
×
Hematologic Tests
×
Clear all
NCT05648240
2026-02-10
EARDIS
Centre Hospitalier Universitaire de NÄ«mes
Completed
120 enrolled
NCT03868046
2025-04-01
AUTENTIC
Hospital Universitario Araba
Completed
242 enrolled